CABOMETYX 20 MG
Cabozantinib
Public price
53.391,00 MAD
Active substance
Cabozantinib
Laboratory
SOTHEMA
What is this medicine?
CABOMETYX 20 MG contains Cabozantinib. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
Cabozantinib, Flacon de 30, 20 MG, Comprimé pelliculé
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Agent antinéoplasique, inhibiteur de la protéine kinase
Laboratory
SOTHEMA
Strength
20 MG
Form
Flacon de 30
Presentation
Comprimé pelliculé
Therapeutic class
Agent antinéoplasique, inhibiteur de la protéine kinase
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 53.391,00 MAD
Available presentations and strengths
CABOMETYX
20 MG · BOITE D'UN FLACON DE 30 COMPRIMES PELLICULES
53,39 MAD
CABOMETYX
40 MG · BOITE D'UN FLACON DE 30 COMPRIMES PELLICULES
53,39 MAD
CABOMETYX
60 MG · BOITE D'UN FLACON DE 30 COMPRIMES PELLICULES
53,39 MAD
CABOMETYX 20 MG
20 MG · Flacon de 30
53.391,00 MAD
CABOMETYX 40 MG
40 MG · Flacon de 30
53.391,00 MAD
CABOMETYX 40 MG
40 MG · Comprimé pelliculé
53.391,00 MAD
CABOMETYX 60 MG
60 MG · Flacon de 30
53.391,00 MAD
CABOMETYX 60 MG
60 MG · Comprimé pelliculé
53.391,00 MAD